Efficacy of nivolumab in the treatment of metastatic cutaneous squamous cell carcinoma in a kidney-transplant patient with a history of allograft rejection

Ann Dermatol Venereol. 2022 Sep;149(3):198-199. doi: 10.1016/j.annder.2022.01.003. Epub 2022 Feb 15.

Authors

S Bastos¹, W Masmoudi², C Pinard², A-B Duval-Modeste², P Joly², V Hébert²

Affiliations

¹ Department of Dermatology, Rouen University Hospital, 76000 Rouen, France. Electronic address: [email protected].
² Department of Dermatology, Rouen University Hospital, 76000 Rouen, France.

PMID: 35181155
DOI: 10.1016/j.annder.2022.01.003

No abstract available

Keywords: Cutaneous squamous cell carcinoma; Kidney transplant; Nivolumab.

Publication types

Letter

MeSH terms

Allografts / pathology
Carcinoma, Squamous Cell* / drug therapy
Carcinoma, Squamous Cell* / secondary
Humans
Kidney / pathology
Nivolumab / therapeutic use
Skin Neoplasms* / drug therapy
Skin Neoplasms* / pathology

Substances

Nivolumab